National Health (Weighted average disclosed price – April 2019 reduction day) Amendment Determination 2019 (PB 9 of 2019) (Cth)

PB 9 of 2019

National Health (Weighted average disclosed price – April 2019 reduction day) Amendment Determination 2019

National Health Act 1953

I, ADRIANA PLATONA, First Assistant Secretary, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated:   19 February 2019

ADRIANA PLATONA

First Assistant Secretary

Technology Assessment and Access Division

Department of Health

1. Name of Instrument

(1)     This instrument is the National Health (Weighted average disclosed price – April 2019 reduction day) Amendment Determination 2019.

(2)     This instrument may also be cited as PB 9 of 2019.

1. Commencement

This instrument commences on the day after it is registered.

1. Amendments to PB 42 of 2018

Schedule 1 amends the National Health (Weighted average disclosed price – April 2019 reduction day) Determination 2018 (PB 109 of 2018)

Schedule 1     Amendments

[1]     Schedule 2

after:

1458 Hyoscine Injection containing hyoscine butylbromide 20 mg in 1 mL Injection HYOSCINE BUTYLBROMIDE SXP 10.88

insert:

1458A	Hypromellose	Eye drops 3 mg per mL, 10 mL	Application to the Eye	Genteal	2.08
1458B	Hypromellose	Eye drops 3 mg per mL, 10 mL	Application to the Eye	In a Wink Moisturising	2.08